Consent for clinicians

It has now been over 3 years since the landmark decision of Montgomery v Lanarkshire Health Board in 2015 which changed the legal landscape regarding informed consent. Montgomery made it clear that consent should be an ongoing and patient centred process, requiring clinicians to ensure that a patient is aware of any material risks involved in any recommended treatment and of any reasonable alternative or variant treatments. Since Montgomery, there have been a number of cases which have refined and clarified the law in this area.

.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }

In this video, Kelly Buckley and Lucy Erskine provide an insight into the current legal position and offer practical tips to ensure that clinicians are having the genuine dialogue needed with patients about relevant treatment options and risks to enable valid consent to be obtained.